Læknablaðið - 15.10.1992, Síða 21

LÆKNABLAÐIÐ
329
18. Pincus T, Olsen NJ, Russell 1J, et al. Multicenter
study of recombinant human erythropoietin in
correction of anemia in rheumatoid arthritis. Am J
Med 1990; 89: 161-8.
19. Takashina N, KOndo H, Kashiwazaki S. Suppressed
serum erythropoietin response to anemia and the
efficacy of recombinant erythropoietin in anemia of
rheumatoid arthritis. J Rheumatol 1990; 17: 885-7.
20. Amett FC, Edworthy SM, Bloch DA, et al. The
American Rheumatism Association 1987. Revised
criteria for the classification of rheumatoid arthrilis.
Arthritis Rheum 1988; 31: 315-24.
21. Bennet PH, Wood PHN. Population studies of
the rheumatic diseases: Proceeding of the third
intemational symposium. New York, June 1966.
Amsterdam: Excerpta Medica, 1968: 456-7.
22. Stone WJ, Graber SE, Krantz SB, et al. Treatment of
the anemia of pre-dialysis patients with recombinant
human erythropoietin. Am J Med Sci 1988; 296: 171-
9.
23. Ritchie DM, Boyle JA, Mclnnes JM, et al. Clinical
studies with an articular index for the assessment of
joint tendemess in patients with rheumatoid arthritis.
Quarterly J Med New Series 1968; 37: 393-406.
24. Steinbrocker O, Traeger CH, Batterman RC.
Therapeutic criteria in rheumatoid arthritis. JAMA
1949; 140: 659-64.
25. Wide L, Bengtsson C, Birgegárd G. Circadian rhythm
of erythropoietin in human serum. Br J Haematol
1989; 72: 85-90.
26. Maury CPJ, Andersson LC, Teppo AM, Partanen S,
Juvonen E. Mechanisms of anemia in rheumatoid
arthritis: demonstration of raised interleukin-lb
consentrations in anemic patients and of interleukin-1
mediated suppression of normal erythropoiesis and
proliferation of human erythroleukemia (HEL) cells
in vitro. Am Rheum Dis 1988; 47: 972-87.
27. Roodman GD. Mechanisms of erythroid suppression
in anemia of chronic disease. Blood Cells 1987; 13:
171-84.